Vergoeding 2015-2019 voor ATC-subgroep L02BA : Anti-oestrogenen
- Raming voor de totale Zvw-populatie
| 2015 | 2016 | 2017 | 2018 | 2019 | |
|---|---|---|---|---|---|
| L02BA01 Tamoxifen | 1.843.900 | 1.831.700 | 1.522.000 | 1.282.400 | 1.334.700 |
| L02BA03 Fulvestrant (Faslodex ®) | 4.020.800 | 5.067.600 | 6.864.800 | 8.474.000 | 9.007.700 |
| Totaal | 5.864.700 | 6.899.300 | 8.386.800 | 9.756.400 | 10.342.400 |